695 related articles for article (PubMed ID: 18580330)
1. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
Franiel T; Lüdemann L; Rudolph B; Rehbein H; Staack A; Taupitz M; Prochnow D; Beyersdorff D
Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].
Franiel T; Lüdemann L; Taupitz M; Rost J; Asbach P; Beyersdorff D
Rofo; 2009 Jun; 181(6):536-42. PubMed ID: 19353483
[TBL] [Abstract][Full Text] [Related]
3. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
Franiel T; Lüdemann L; Taupitz M; Böhmer D; Beyersdorff D
Radiother Oncol; 2009 Nov; 93(2):241-5. PubMed ID: 19748143
[TBL] [Abstract][Full Text] [Related]
4. Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters.
Franiel T; Lüdemann L; Rudolph B; Rehbein H; Stephan C; Taupitz M; Beyersdorff D
Radiology; 2009 Jul; 252(1):101-8. PubMed ID: 19561252
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of prostate cancer from normal prostate tissue: role of hotspots in pharmacokinetic MRI and histologic evaluation.
Franiel T; Lüdemann L; Rudolph B; Lutterbeck E; Hamm B; Beyersdorff D
AJR Am J Roentgenol; 2010 Mar; 194(3):675-81. PubMed ID: 20173144
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
8. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
Kim JK; Hong SS; Choi YJ; Park SH; Ahn H; Kim CS; Cho KS
J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
[TBL] [Abstract][Full Text] [Related]
9. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
10. Interscanner comparison of dynamic contrast-enhanced MRI in prostate cancer: 1.5 versus 3 T MRI.
Sertdemir M; Schoenberg SO; Sourbron S; Hausmann D; Heinzelbecker J; Michaely HJ; Dinter DJ; Weidner AM
Invest Radiol; 2013 Feb; 48(2):92-7. PubMed ID: 23249646
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantification of perfusion and permeability in the prostate using dynamic contrast-enhanced magnetic resonance imaging with an inversion-prepared dual-contrast sequence.
Lüdemann L; Prochnow D; Rohlfing T; Franiel T; Warmuth C; Taupitz M; Rehbein H; Beyersdorff D
Ann Biomed Eng; 2009 Apr; 37(4):749-62. PubMed ID: 19169821
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
14. Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer.
Eyal E; Bloch BN; Rofsky NM; Furman-Haran E; Genega EM; Lenkinski RE; Degani H
Invest Radiol; 2010 Apr; 45(4):174-81. PubMed ID: 20177391
[TBL] [Abstract][Full Text] [Related]
15. 3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1).
Bloch BN; Rofsky NM; Baroni RH; Marquis RP; Pedrosa I; Lenkinski RE
Acad Radiol; 2004 Aug; 11(8):863-7. PubMed ID: 15288036
[TBL] [Abstract][Full Text] [Related]
16. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
Kershaw LE; Hutchinson CE; Buckley DL
J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
[TBL] [Abstract][Full Text] [Related]
17. Effects of water exchange on MRI-based determination of relative blood volume using an inversion-prepared gradient echo sequence and a blood pool contrast medium.
Carreira GC; Gemeinhardt O; Beyersdorff D; Schnorr J; Taupitz M; Lüdemann L
Magn Reson Imaging; 2009 Apr; 27(3):360-9. PubMed ID: 18768279
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
Cornud F; Beuvon F; Thévenin F; Chauveinc L; Vieillefond A; Descazeaux A; Flam T
Prog Urol; 2009 Jun; 19(6):401-13. PubMed ID: 19467459
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
Kitajima K; Kaji Y; Fukabori Y; Yoshida K; Suganuma N; Sugimura K
J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a rapid inversion-prepared dual-contrast gradient echo sequence for quantitative dynamic contrast-enhanced magnetic resonance imaging of the human prostate.
Prochnow D; Beyersdorff D; Warmuth C; Taupitz M; Gemeinhardt O; Lüdemann L
Magn Reson Imaging; 2005 Dec; 23(10):983-90. PubMed ID: 16376181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
